Montgomery Pill Mill Doctor Pleads Guilty To Drug Distribution, Health Care Fraud And Money Laundering Charges
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Montgomery Pill Mill Doctor Pleads Guilty To Drug Distribution, Health Care Fraud And Money Laundering Charges

Montgomery Pill Mill Doctor Pleads Guilty To Drug Distribution, Health Care Fraud And Money Laundering Charges

November 28, 2017
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Public Information Officer
Phone Number: 571-362-2805

MONTGOMERY, Ala. - Dr. Gilberto Sanchez, 56, of Cecil, Alabama, pleaded guilty today to drug distribution conspiracy, health care fraud, and money laundering charges, announced Drug Enforcement (DEA) Assistant Special Agent in Charge Bret Hamilton and United States Attorney Louis V. Franklin, Sr. from the Middle District of Alabama.

According to court documents, beginning on an unknown date and continuing until he was arrested on August 1, 2017, Dr. Sanchez operated a “pill mill” through Family Practice, a medical clinic he owned located at 4143 Atlanta Highway in Montgomery, Alabama.  A “pill mill” is a medical clinic that is dispensing controlled substances inappropriately, unlawfully, and for non-medical reasons.  At Family Practice, Dr. Sanchez conspired with other health care providers working for him to prescribe controlled substances to patients even though they did not actually need the medicines.  Among the controlled substances Dr. Sanchez and his colleagues unnecessarily prescribed were oxycodone, hydrocodone, methadone, hydromorphone, amphetamine, and fentanyl. 

As for the health care fraud charge, the court documents indicate that Dr. Sanchez and his colleagues required patients of Family Practice to return for monthly physical examinations before the patients could receive prescription refills.  Such monthly examinations were not medically necessary, as the patients had no real medical condition that required the prescribing of controlled substances in the first place.  Dr. Sanchez and the Family Practice employees would then bill health insurance companies and government health insurance (including Medicare and Medicaid) for the cost of these unnecessary monthly examinations.

The money laundering charges stem from Dr. Sanchez’s spending the proceeds of his operation of a pill mill.  Court documents describe Dr. Sanchez using those proceeds to purchase at least one vehicle and one personal residence located in Montgomery. 

 Dr. Sanchez’s sentencing date has not yet been set.  At sentencing, he faces a maximum of 20 years in prison on the drug conspiracy count and maximum sentences of 10 years imprisonment on the health care fraud and money laundering counts.  There is no parole in the federal system.  He also faces substantial monetary penalties, restitution, and forfeiture of assets purchased with the proceeds of his crimes. 

 “The abuse of prescription drugs is a serious problem in our communities’ said DEA Assistant Special Agent in Charge Bret Hamilton.  “All too often, this abuse leads to addiction, shattered lives, or even death.  For the health and safety of our citizens, the DEA and our federal, state, and local law enforcement partners will continue to target those who illegally distribute these dangerous drugs.”

“We have seen first-hand in Montgomery the harm that our country’s opioid epidemic causes,” stated United States Attorney Franklin.  “Too many lives have been destroyed as a result of the illegitimate prescribing of these pills.  Dr. Sanchez, and others like him, have led us to this point and I am proud that he will face the consequences of placing profit over the well-being of his patients and our community.” 

This case was investigated by the DEA’s Tactical Diversion Squad, the Internal Revenue Service’s Criminal Investigation Division, and the Department of Health and Human Services - Office of Inspector General.  The Montgomery County, Alabama Sheriff’s Office, the Alabama Board of Medical Examiners, the Montgomery, Alabama Police Department, and the Opelika, Alabama Police Department all assisted in the investigation. 

Parents and children are encouraged to educate themselves about the dangers of drugs by visiting DEA’s interactive websites at www.JustThinkTwice.com, www.GetSmartAboutDrugs.com and www.dea.gov.  

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Steven L. Hofer Special Agent in Charge - New Orleans
@DEANewOrleans
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster